We are not able to resolve this OAI Identifier to the repository landing page. If you are the repository manager for this record, please head to the Dashboard and adjust the settings.
<p>In the presence of anti-EBA-175<sub>RII</sub> antibodies (<b>A</b>; black bars), inhibition when using the Dd2 strain is only 60% (Ab concentration of100 µg/mL), compared to 55% inhibition from 3D7, suggesting alternative SA dependent pathways are utilized by Dd2, such as EBL-1/GPB or EBA-140/GPC (for <b>A</b>, <b>B</b> and <b>C</b>, Dd2 with its control IgG shown as solid white bars). Although anti-rRH5 antibodies (<b>B</b>; blue bars), should only block a SA independent pathway, there is still greater inhibition with Dd2 compared to 3D7. In the presence of both antibodies (<b>C</b>; anti-EBA-175<sub>RII</sub>/rRH5 shown as red bars and anti-EBA-175<sub>RII</sub>+anti-rRH5 shown as green bars, respectively), there is a significant difference in the ability of Dd2 to invade compared to 3D7, especially when individual antibodies are combined.</p
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.